Phase II study of oxaliplatin and taxotere [docetaxel] in metastatic bladder cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2011
At a glance
- Drugs Docetaxel; Oxaliplatin
- Indications Bladder cancer
- Focus Adverse reactions
- 29 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Aug 2007 Status changed from recruiting to in progress.
- 29 Oct 2005 New trial record.